Camrelizumab-Related Lethal Arrhythmias and Myasthenic Crisis in a Patient with Metastatic Thymoma
Immune checkpoint inhibitors (ICIs) have emerged in recent years as promising treatment options for several malignant tumors. However, ICI therapy has also been associated with various immune-related adverse events (irAEs), especially for patients with preexisting autoimmune status, which sometimes...
Saved in:
Main Authors: | Bo Zhang, Laxman Gyawali, Zengzhang Liu, Huaan Du, Yuehui Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2022/4042909 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Edema in Myasthenic Crisis
by: Uttara Swati Anand, et al.
Published: (2013-01-01) -
Sepsis Management in a Case of Myasthenic Crisis: A Case Report
by: Hossein Karballaei Mirzahosseini, et al.
Published: (2024-07-01) -
Case report: Successful perioperative intervention with efgartigimod in a patient in myasthenic crisis
by: Shahar Shelly
Published: (2025-01-01) -
Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma
by: Yinfang Gu, et al.
Published: (2025-02-01) -
Thymoma. Case report
by: Miguel Acebo Rodríguez, et al.
Published: (2024-05-01)